Treatment with hydroxyurea in a patient compound heterozygote for a high oxygen affinity hemoglobin and β-thalassemia minor

Autor: Ghislain Cournoyer, Carmen Gagnon, Denis Soulières, Pierre-Olivier Gaudreau, Louise Robin, Xiaoduan Weng

Publikováno v: American Journal of Hematology. 84:766-768

Compound heterozygotes for β-thalassemia and high oxygen affinity hemoglobin (Hb) have been documented, but experience in the management of such rare cases is minimal. Although hydroxyurea (HU) has never been used in a heterozygote with high oxygen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4789bcefff33b1ab7a43155bb45c8edd
https://doi.org/10.1002/ajh.21526

ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit

Autor: Jean-Philippe Gratton, Ghislain Cournoyer, Bernd-Michael Löffler, Pedro D’Orléans-Juste, Pierre Sirois

Publikováno v: Hypertension (Dallas, Tex. : 1979). 30(5)

Abstract Endothelin-1 (0.25 nmol/kg, injected into the left cardiac ventricle) induces a protracted increase of mean arterial pressure that is significantly reduced by the selective ET A receptor antagonist BQ-123 (1 and 10 mg/kg) in the anesthetized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63fdc963cd283acce9c4a07e41d129f
https://pubmed.ncbi.nlm.nih.gov/9369277

Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.

Autor: Boily G; Institut national d'excellence en santé et en service sociaux (INESSS), Québec; †Hôpital Notre-Dame (CHUM), Montréal; ‡Hôpital Maisonneuve-Rosemont, Montréal; §Montreal General Hospital (MUHC), Montréal; ‖Institut universitaire de cardiologie et de pneumologie de Québec, Québec; ¶Hôpital Charles-LeMoyne (CSSS Champlain-Charles-LeMoyne), Greenfield Park; #Hôpital de la Cité-de-la-Santé (CSSS de Laval), Laval, Québec, Canda; and **The Comité de l'évolution des pratiques en oncologie (CEPO), a group of specialists in oncology that reports to the INESSS. Its role is to provide physicians and other health professionals in the field of oncology with evidence-based guidelines and clinical support tools to optimize and standardize clinical practice in the province of Québec, Canada. The CEPO's members are Karine Almanric, BPharm, MSc, BCOP, Hôpital de la Cité-de-la-Santé (CSSS de Laval); Jean-Sébastien Aucoin, MD, Centre hospitalier affilié universitaire régional (CSSS de Trois-Rivières); Gino Boily, PhD, INESSS; Philippe Bouchard BPharm, MSc, BCOP, Hôpital Maisonneuve-Rosemont; Jim Boulanger, PhD, INESSS; Alexis Bujold, MD, Hôpital Maisonneuve-Rosemont; Ghislain Cournoyer, MD, Hôpital régional de Saint-Jérôme (CSSS de Saint-Jérôme); Félix Couture, MD, Hôtel-Dieu de Québec (CHU de Québec); Normand Gervais, MD, Centre hospitalier régional du Grand-Portage (CSSS de Rivière-du-Loup); Stéphanie Goulet, PhD, INESSS; Marie-Pascale Guay, BPharm, MSc, BCOP, Jewish General Hospital (MUHC); Bernard Lespérance, MD, Hôpital du Sacré-Cœur de Montréal, Groupe d'étude en oncologie du Québec; Nathalie Letarte, BPharm, MSc, BCOP, Hôpital Notre-Dame (CHUM), Programme de gestion thérapeutique des médicaments; Jean-François Ouellet, MD, Hôtel-Dieu de Québec (CHU de Québec); Gilles Pineau, MD, INESSS; Raghu Rajan, MD, Montreal General Hospital (MUHC); Isabelle Roy, MD, Hôpital de la Cité-de-la-Santé (CSSS de Laval); Benoît Samson, Filion É, Rakovich G, Kopek N, Tremblay L, Samson B, Goulet S, Roy I

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2015 Jun; Vol. 10 (6), pp. 872-82.